Prothymosin α lacking the nuclear localization signal as an effective gene therapeutic strategy in collagen-induced arthritis

Journal of Immunology

Volumn 178, Issue 7, 2007, Pages 4688-4694

  Shiau, Ai Li ^a   Chen, Shih Yao ^a   Chang, Meng Ya ^a   Su, Chih Hau ^a   Chung, Shih Ye ^a   Yo, Yi Te ^a   Wang, Chrong Reen ^a   Wu, Chao Liang ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; COLLAGEN; CYTOKINE; GELATINASE B; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; PROTHYMOSIN ALPHA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANKLE; ARTICLE; CELL INFILTRATION; CHEMOTAXIS; CLINICAL FEATURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; FIBROBLAST; HISTOLOGY; HUMAN; HUMAN CELL; MALE; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOGRAPHY; RAT; RHEUMATOID ARTHRITIS; SINGLE DRUG DOSE; SYNOVIUM; VIRAL GENE THERAPY;

EID: 33947622728     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.7.4688     Document Type: Article

References (52)

1. Firestein, G. S. 2003. Evolving concepts of rheumatoid arthritis. Nature 423: 356-361.
2. Ritchlin, C., E. Dwyer, R. Bucala, and R. Winchester. 1994. Sustained and distinctive patterns of gene activation in synovial fibroblasts and whole synovial tissue obtained from inflammatory synovitis. Scand. J. Immunol. 40: 292-298.
3. Bucala, R., C. Ritchlin, R. Winchester, and A. Cerami. 1991. Constitutive production of inflammatory and mitogenic cytokines by rheumatoid synovial fibroblasts. J. Exp. Med. 173: 569-574.
4. Zagury, D., and R. C. Gallo. 2004. Anti-cytokine Ab immune therapy: present status and perspectives. Drug Discov. Today 9: 72-81.
5. Bendele, A., T. McAbee, G. Sennello, J. Frazier, E. Chlipala, and D. McCabe. 1999. Efficacy of sustained blood levels of interleukin-1 receptor antagonist in animal models of arthritis: comparison of efficacy in animal models with human clinical data. Arthritis Rheum. 42: 498-506.
6. Jou, I. M., A. L. Shiau, S. Y. Chen, C. R. Wang, D. B. Shieh, C. S. Tsai, and C. L. Wu. 2005. Thrombospondin 1 as an effective gene therapeutic strategy in collagen-induced arthritis. Arthritis Rheum. 52: 339-344.
7. Wang, C. R., S. Y. Chen, C. L. Wu, M. F. Liu, Y. T. Jin, L. Chao, and J. Chao. 2005. Prophylactic adenovirus-mediated human kallistatin gene therapy suppresses rat arthritis by inhibiting angiogenesis and inflammation. Arthritis Rheum. 52: 1319-1324.
8. Low, T. L., G. B. Thurman, M. McAdoo, J. McClure, J. L. Rossio, P. H. Naylor, and A. L. Goldstein. 1979. The chemistry and biology of thymosin. I. Isolation, characterization, and biological activities of thymosin 1α1 and polypeptide β1 from calf thymus. J. Biol. Chem. 254: 981-986.
9. Wu, C. L., A. L. Shiau, and C. S. Lin. 1997. Prothymosin α promotes cell proliferation in NIH3T3 cells. Life Sci. 61: 2091-2101.
10. Baxevanis, C. N., A. D. Gritzapis, G. V. Dedoussis, N. G. Papadopoulos, O. Tsolas, and M. Papamichail. 1994. Induction of lymphokine-activated killer activity in mice by prothymosin α. Cancer Immunol. Immunother. 38: 281-286.
11. Baxevanis, C. N., A. D. Gritzapis, G. Spanakos, O. E. Tsitsilonis, and M. Papamichail. 1995. Induction of tumor-specific T lymphocyte responses in vivo by prothymosin α. Cancer Immunol. Immunother. 40: 410-418.
12. Eckert, K., E. Grunberg, P. Immenschuh, F. Garbin, E. D. Kreuser, and H. R. Maurer. 1997. Interleukin-2-activated killer cell activity in colorectal tumor patients: evaluation of in vitro effects by prothymosin α1. J. Cancer Res. Clin. Oncol. 123: 420-428.
13. Pineiro, A., O. J. Cordero, and M. Nogueira. 2000. Fifteen years of prothymosin α: contradictory past and new horizons. Peptides 21: 1433-1446.
14. Cordero, O. J., H. R. Maurer, and M. Nogueira. 1997. Novel approaches to immunotherapy using thymic peptides. Immunol. Today 18: 10-13.
15. Baxevanis, C. N., C. Sfagos, E. Anastasopoulos, G. J. Reclos, and M. Papamichail. 1990. Prothymosin-α enhances HLA-DR antigen expression on monocytes from patients with multiple sclerosis. J. Neuroimmunol. 27: 141-147.
16. Baxevanis, C. N., G. J. Reclos, M. Papamichail, and G. C. Tsokos. 1987. Prothymosin α restores the depressed autologous and allogeneic mixed lymphocyte responses in patients with systemic lupus erythematosus. Immunopharmacol. Immunotoxicol. 9: 429-440.
17. Gaubatz, S., A. Meichle, and M. Eilers. 1994. An E-box element localized in the first intron mediates regulation of the prothymosin α gene by c-myc. Mol. Cell. Biol. 14: 3853-3862.
18. Qu, Z., C. H. Garcia, L. M. O'Rourke, S. R. Planck, M. Kohli, and J. T. Rosenbaum. 1994. Local proliferation of fibroblast-like synoviocytes contributes to synovial hyperplasia: results of proliferating cell nuclear antigen/cyclin, c-myc, and nucleolar organizer region staining. Arthritis Rheum. 37: 212-220.
19. Volin, M. V., and A. E. Koch. 2000. Cell cycle implications in the pathogenesis of rheumatoid arthritis. Front. Biosci. 5: D594-D601.
20. Pap, T., M. Nawrath, J. Heinrich, M. Bosse, A. Baier, K. M. Hummel, P. Petrow, S. Kuchen, B. A. Michel, R. E. Gay, et al. 2004. Cooperation of Ras- and c-Myc-dependent pathways in regulating the growth and invasiveness of synovial fibroblasts in rheumatoid arthritis. Arthritis Rheum. 50: 2794-2802.
21. Bodey, B., B. Bodey, Jr., S. E. Siegel, and H. E. Kaiser. 2000. Review of thymic hormones in cancer diagnosis and treatment. Int. J. Immunopharmacol. 22: 261-273.
22. Wolf, R. E., and V. C. Hall. 1987. Interleukin-2 production and effect of thymosin fraction 5 on interleukin-2 production in rheumatoid arthritis. J. Rheumatol. 14: 898-901.
23. + T cells from the target organ of patients with rheumatoid arthritis. Eur. J. Immunol. 33: 215-223.
24. Ehrenstein, M. R., J. G. Evans, A. Singh, S. Moore, G. Warnes, D. A. Isenberg, and C. Mauri. 2004. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFα therapy. J. Exp. Med. 200: 277-285.
25. Zatz, M. M., J. Oliver, A. L. Goldstein, C. Novak, and R. P. Jacobs. 1984. Suppressor cell responses in patients with rheumatoid arthritis: the effect of thymosin. Thymus 6: 205-218.
26. Manrow, R. E., A. R. Sburlati, J. A. Hanover, and S. L. Berger. 1991. Nuclear targeting of prothymosin α. J. Biol. Chem. 266: 3916-3924.
27. Shiau, A. L., P. R. Lin, M. Y. Chang, and C. L. Wu. 2001. Retrovirus-mediated transfer of prothymosin gene inhibits tumor growth and prolongs survival in murine bladder cancer. Gene Ther. 8: 1609-1617.
28. Hitt, M., A. J. Bett, L. Prevec, and F. L. Graham. 1998. Construction and propagation of human adenovirus vectors. In Cell Biology: A Laboratory Handbook. I. E. Celis, ed. Academic Press, San Diego, pp. 479-490.
29. Li, K. J., A. L. Shiau, Y. Y. Chiou, Y. T. Yo, and C. L. Wu. 2005. Transgenic overexpression of prothymosin α induces development of polycystic kidney disease. Kidney Int. 67: 1710-1722.
30. Bristow, C. A., and P. Shore. 2003. Transcriptional regulation of the human MIP-1α promoter by RUNX1 and MOZ. Nucleic Acids Res. 31: 2735-2744.
31. Malo, M. S., M. Abedrapo, A. Chen, M. Mozumder, P. Pushpakaran, F. Alkhoury, W. Zhang, E. Fleming, and R. A. Hodin. 2003. Improved eukaryotic promoter-detection vector carrying two luciferase reporter genes. BioTechniques 35: 1150-1152, 1154.
32. Woods, I. M., K. I. Katschke, M. V. Volin, I. H. Ruth, D. C. Woodruff, M. A. Amin, M. A. Connors, H. Kurata, K. Arai, G. K. Haines, et al. 2001. IL-4 adenoviral gene therapy reduces inflammation, proinflammatory cytokines, vascularization, and bony destruction in rat adjuvant-induced arthritis. J. Immunol. 166: 1214-1222.
33. Asahara, H., T. Hasunuma, T. Kobata, H. Inoue, U. Muller-Ladner, S. Gay, T. Sumida, and K. Nishioka. 1997. In situ expression of protooncogenes and Fas/Fas ligand in rheumatoid arthritis synovium. J. Rheumatol. 24: 430-435.
34. Wolpe, S. D., G. Davatelis, B. Sherry, B. Beutler, D. G. Hesse, H. T. Nguyen, L. L. Moldawer, C. F. Nathan, S. F. Lowry, and A. Cerami. 1988. Macrophages secrete a novel heparin-binding protein with inflammatory and neutrophil chemokinetic properties. J. Exp. Med. 167: 570-581.
35. Menten, P., A. Wuyts, and J. Van Damme. 2002. Macrophage inflammatory protein-1. Cytokine Growth Factor Rev. 13: 455-481.
36. Katrib, A., P. P. Tak, J. V. Bertouch, C. Cuello, H. P. McNeil, T. J. M. Smeets, M. C. Kraan, and P. P. Youssef. 2001. Expression of chemokines and matrix metalloproteinases in early rheumatoid arthritis. Rheumatology 40: 988-994.
37. Koch, A. E., S. L. Kunkel, L. A. Harlow, D. D. Mazarakis, G. K. Haines, M. D. Burdick, R. M. Pope, and R. M. Stricter. 1994. Macrophage inflammatory protein-1α: a novel chemotactic cytokine for macrophages in rheumatoid arthritis. J. Clin. Invest. 93: 921-928.
38. Kasama, T., R. M. Stricter, N. W. Lukacs, P. M. Lincoln, M. D. Burdick, and S. L. Kunkel. 1995. Interleukin-10 expression and chemokine regulation during the evolution of murine type II collagen-induced arthritis. J. Clin. Invest. 95: 2868-2876.
39. Shahrara, S., M. A. Amin, J. M. Woods, G. K. Haines, and A. E. Koch. 2003. Chemokine receptor expression and in vivo signaling pathways in the joints of rats with adjuvant-induced arthritis. Arthritis Rheum. 48: 3568-3583.
40. Kagari, T., H. Doi, and T. Shimozato. 2002. The importance of IL-1β and TNF-α, and the noninvolvement of IL-6, in the development of monoclonal antibody-induced arthritis. J. Immunol. 169: 1459-1466.
41. Sosne, G., C. C. Chan, K. Thai, M. Kennedy, E. A. Szliter, L. D. Hazlett, and H. K. Kleinman. 2001. Thymosin β4 promotes corneal wound healing and modulates inflammatory mediators in vivo. Exp. Eye Res. 72: 605-608.
42. Hiltunen, M. O., M. Ruuskanen, J. Huuskonen, A. J. Mahonen, M. Ahonen, J. Rutanen, V. M. Kosma, A. Mahonen, H. Kroger, and S. Yla-Herttuala. 2003. Adenovirus-mediated VEGF-A gene transfer induces bone formation in vivo. FASEB J. 17: 1147-1149.
43. Gowen, M., K. Chapman, A. Littlewood, D. Hughes, D. Evans, and G. Russell. 1990. Production of tumor necrosis factor by human osteoblasts is modulated by other cytokines, but not by osteotropic hormones. Endocrinology 126: 1250-1255.
44. Swolin-Eide, D., and C. Ohlsson. 1998. Effects of cortisol on the expression of interleukin-6 and interleukin-1β in human osteoblast-like cells. J. Endocrinol. 156: 107-114.
45. Chae, H. J., S. C. Kim, S. W. Chae, N. H. An, H. H. Kim, Z. H. Lee, and H. R. Kim. 2001. Blockade of the p38 mitogen-activated protein kinase pathway inhibits inducible nitric oxide synthase and interleukin-6 expression in MC3T3E-1 osteoblasts. Pharmacol. Res. 43: 275-283.
46. Dovio, A., M. L. Sartori, R. G. Masera, L. Peretti, L. Perotti, and A. Angeli. 2004. Effects of physiological concentrations of steroid hormones and interleukin-11 on basal and stimulated production of interleukin-8 by human osteoblast-like cells with different functional profiles. Clin. Exp. Rheumatol. 22: 79-84.
47. Taichman, R. S., M. J. Reilly, and L. S. Matthews. 2000. Human osteoblast-like cells and osteosarcoma cell lines synthesize macrophage inhibitory protein 1α in response to interleukin 1β and tumor necrosis factor α stimulation in vitro. Br. J. Haematol. 108: 275-283.
48. Muruve, D. A. 2004. The innate immune response to adenovirus vectors. Hum. Gene Ther. 15: 1157-1166.
49. Kinne, R. W., R. Brauer, B. Stuhlmuller, E. Palombo-Kinne, and G. R. Burmester. 2000. Macrophages in rheumatoid arthritis. Arthritis Res. 2: 189-202.
50. + blood monocytes and joint inflammation in rheumatoid arthritis. Arthritis Rheum. 46: 2578-2586.
51. Szekanecz, Z., G. Szucs, S. Szanto, and A. E. Koch. 2006. Chemokines in rheumatic diseases. Curr. Drug Targets 7: 91-102.
52. Tetlow, L. C., M. Lees, Y. Ogata, H. Nagase, and D. E. Woolley. 1993. Differential expression of gelatinase B (MMP-9) and stromelysin-1 (MMP-3) by rheumatoid synovial cells in vitro and in vivo. Rheumatol. Int. 13: 53-59.